Menu

Salarius Pharmaceuticals, Inc. SLRX

Full chart Compare
Set alert

Price alert · SLRX

All alert types
0.84 USD 0.00 (+0.00%)

At closeJan 7, 2026, 4:00 PM EST

0.83 -0.01 -1.18%

After hours · Jan 7, 4:00 PM ET

0.6865 Day range 0.8976

52-week range unavailable

YTD
+29.47%
1 year
-96.73%

Revenue & Expenses

Other Income → Expenses: $44.69KExpenses → Selling, General & Admin: $6.10MExpenses → Research & Development: $8.55MGross Profit → Expenses: $1.84MRevenue → Gross Profit: $1.84MNet Loss → Expenses: $12.77MOther Income$44.69KGross Profit$1.84MNet Loss$12.77MExpenses$14.65MSelling, General & Admin$6.10MResearch & Development$8.55MRevenue$1.84M

Latest period ending Dec 31, 2024 · select a line to chart its full history

SLRX annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-5.73M-12.89M-31.84M-12.81M-7.79M
-5.58M-12.54M-31.61M-12.77M-7.35M
-87.00-461.00-1,786.00-926.00-1,500.00
SLRX annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
2.43M5.90M12.11M29.21M11.12M
3.02M6.59M14.65M40.83M24.93M
1.51M1.30M4.27M2.11M2.77M
221.87K289.64K00477.03K
1.51M5.29M10.38M38.72M22.16M
SLRX annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-4.53M-12.85M-17.60M-10.20M-10.31M
1.06M6.64M1.99M28.30M17.69M
-3.47M-6.21M-17.11M18.10M7.38M